Opinion: Emergency use authorization of Covid-19 vaccines could hinder global access to them
Within the span of 10 days, regulators in the United Kingdom and the United States granted emergency use authorization for the Covid-19 vaccine made by Pfizer and BioNTech.
This vaccine, reported to be 95% effective, is now being rolled out across both countries. And as I write this, the U.S. is poised to approve a second Covid-19 vaccine, this one made by Moderna.
